After being diagnosed with a sexually transmitted infection (STI), how long should a person abstain from vaginal, anal, and oral sexual activity until the infection is fully treated and no longer infectious?

Duration of Sexual Abstinence After STI Diagnosis

Patients diagnosed with a sexually transmitted infection must abstain from all sexual activity—including vaginal, anal, and oral sex—for 7 days after initiating single-dose therapy (such as azithromycin) or until completing a full 7-day regimen (such as doxycycline), AND until all sex partners have been adequately treated. 1, 2

Core Abstinence Requirements

• The 7-day rule applies universally across chlamydia, gonorrhea, and other bacterial STIs, regardless of whether the patient receives single-dose azithromycin or multi-day doxycycline. 1, 2

• Both conditions must be met before resuming sexual activity:

  • The patient has completed the full treatment course (7 days from single-dose therapy OR completion of multi-day regimen), AND
  • All sex partners from the preceding 60 days have completed their own treatment courses. 1, 2

• Symptoms must also have resolved before resuming intercourse; if urethral discharge, dysuria, or other symptoms persist beyond 7 days, sexual activity must remain suspended until reevaluation. 1

Why 7 Days Is Critical

• Microbiologic clearance requires time: Even with highly effective antibiotics (97–98% cure rates for azithromycin and doxycycline), viable organisms may persist for several days after the first dose. 2

• Partner treatment is equally essential: Up to 20% of patients experience reinfection when partners are not treated, making partner therapy completion a mandatory prerequisite for resuming sex. 2, 3

• Condoms do not eliminate risk during the treatment window: Although condoms reduce transmission, they are not 100% effective—especially with inconsistent or inexperienced use—and should not be relied upon as a substitute for abstinence during acute infection. 4

Special Considerations for Specific STIs

Chlamydia and Gonorrhea

• Standard 7-day abstinence applies after azithromycin 1 g single dose or doxycycline 100 mg twice daily for 7 days. 1, 2

• Dual therapy for gonorrhea (ceftriaxone 250 mg IM plus azithromycin 1 g orally) still requires the same 7-day abstinence period. 1, 2

Acute Proctitis (Rectal STIs)

• Same 7-day rule: Patients treated for rectal chlamydia or gonorrhea must abstain from receptive anal intercourse for 7 days after starting ceftriaxone plus doxycycline. 1

Lymphogranuloma Venereum (LGV)

• Extended abstinence required: Because LGV treatment requires doxycycline 100 mg twice daily for 21 days (not 7), patients must abstain until completing the full 3-week course AND all partners are treated. 1

Partner Management Is Non-Negotiable

• All sex partners from the preceding 60 days must be evaluated, tested, and treated empirically—even if asymptomatic—using the same regimen as the index patient. 1, 2

• If the most recent sexual contact occurred >60 days before diagnosis, that partner should still be treated. 1, 2

• Expedited partner therapy (EPT) allows clinicians to provide medication or prescriptions directly to partners who cannot attend a clinic visit, increasing treatment rates and reducing reinfection. 1, 2

Common Pitfalls to Avoid

• Do NOT allow sexual activity before 7 days have elapsed, even if symptoms resolve earlier; microbiologic cure lags behind symptom resolution. 1, 2

• Do NOT assume partners were treated based on patient report alone; verify completion or use EPT to ensure medication delivery. 1, 2

• Do NOT rely on condoms as a substitute for abstinence during the 7-day treatment window; condom failure rates are too high in this context. 4

• Do NOT resume sex if symptoms persist beyond 7 days; this may indicate treatment failure, reinfection, or co-infection with Mycoplasma genitalium (which requires alternative therapy). 1, 5

Real-World Adherence Data

• Only 73% of men who have sex with men (MSM) with nongonococcal urethritis avoided urethral sexual exposure for the recommended 7-day period in a prospective cohort study, highlighting the need for clear, emphatic counseling. 5

• 37% of patients had symptoms persisting beyond 7 days after azithromycin treatment for NGU, particularly those with Mycoplasma genitalium (60% had symptoms >7 days); clinicians should warn patients that symptom resolution may take longer than the abstinence period. 5

Follow-Up and Retesting

• Routine test-of-cure is NOT recommended for non-pregnant patients treated with first-line regimens (azithromycin or doxycycline) unless symptoms persist, compliance is questionable, or reinfection is suspected. 1, 2, 6

• All women should be retested 3 months after treatment to detect reinfection (not treatment failure), as reinfection rates reach 39% in some populations and confer elevated risk for pelvic inflammatory disease. 1, 2, 6, 3

• Testing before 3 weeks post-treatment is unreliable because nucleic acid amplification tests (NAATs) can yield false-positive results from dead organisms. 2, 6